Подпишитесь на нашу новостную ленту
Вопрос?
11.06.2026
Getinge elevates automated endoscope reprocessing with Aquadis Endo 110
Today, Getinge announced the launch of Aquadis Endo 110, a next-generation automated endoscope reprocessor designed to increase processing capacity, simplify workflows and enhance safety for both patients and healthcare professionals. Building on decades of expertise in infection control and sterile reprocessing, Aquadis Endo 110 sets a new benchmark for fast, reliable cleaning and high-level disinfection of flexible endoscopes, helping reduce the risk of healthcare‑associated infections.
10.06.2026
Self-sufficient, mobile pediatric heart clinic performs groundbreaking surgeries in Burundi
Supported by several products from global medtech company Getinge, the German non-profit organization kinderherzen continues to save the lives of children in countries with no or inadequate access to cardiac care.
02.06.2026
Getinge Launches Vasoview Hemopro 3, Advancing Endoscopic Vessel Harvesting
Getinge today announced the launch of the Vasoview Hemopro 3 Endoscopic Vessel Harvesting (EVH) System, including the Hemopro 3 Harvesting Tool and dedicated Hemopro 3 Power Supply. Designed for clinicians, by clinicians, the system represents the latest evolution of Getinge’s EVH platform, enhancing decades of experience supporting coronary artery bypass grafting (CABG) procedures.
28.05.2026
Getinge’s subsidiary Maquet Cardiovascular receives adverse jury trial verdict in patent infringement dispute with Abiomed in the U.S.
Getinge today announces that a jury in the United States District Court for the District of Massachusetts has delivered a verdict in favor of Abiomed Inc (“Abiomed”) in a patent dispute between Getinge’s subsidiary Maquet Cardiovascular LLC (“Maquet”) and Abiomed. The jury found that Abiomed has not infringed any Maquet patents relating to intravascular heart pump technology.
21.04.2026
Getinge Interim Report January-March 2026: Organic growth, strong cash flow and regulatory milestone
“We succeeded in surpassing last year’s record-breaking first quarter with organic growth in both net sales and order intake,” says Mattias Perjos, President & CEO at Getinge. The medtech company’s net sales increased organically by 0,8% while the order intake rose by 3,9% organically.
Пресс-контакт
Caroline Örmgård
Head of Public & Media Relations
Tel: +46 10 335 0041
Lars Mattsson
Senior Vice President Enterprise Development
Tel: +46 10 335 0043
Katarzyna Sypuła
Senior Customer Experience Campaigns & Events Manager
CEE/ South Europe / SAPAC
Tel: +48 661 705 706
Предпочитаете связаться с нами онлайн?
Нажмите ниже, чтобы заполнить соответствующую форму. Мы свяжемся с вами в ближайшее время!
Вы ищете
Галерея
Разнообразный формат изображений доступен для статей в прессе
О нас
Все, что вам нужно знать о Getinge одним взглядом
Срочная коррекция медицинского оборудования
Добровольная срочная полевая коррекция медицинского устройства для внутриаортальной баллонной контрпульсации CARDIOSAVE (IABP)
Не пропустите ничего
Кликайте на иконки и подписывайтесь на нас!